Start-Up Spotlight: Elixir Works To 'Uncage' The Coronary After Intervention

Elixir Medical's DynamX Bioadaptor represents a new approach to treating coronary disease, combining the best features of metallic drug-eluting stents and bioresorbable scaffolds.

Despite the enormous progress in drug-eluting stent technology over the last two decades, metallic drug-eluting stents still create a risk for major adverse events long after they have been implanted....